L. Bertilsson et al., CLOZAPINE DISPOSITION COVARIES WITH CYP1A2 ACTIVITY DETERMINED BY A CAFFEINE TEST, British journal of clinical pharmacology, 38(5), 1994, pp. 471-473
In a previous study we showed that the disposition of clozapine after
a single oral dose is unrelated to either debrisoquine or S-mephenytoi
n hydroxylation polymophism. The same 14 healthy subjects studied in t
hat investigation were given 150 mg of caffeine. The reciprocal of pla
sma clozapine AUC (0,24), was correlated with an index of the N3-demet
hylation of caffeine (r(s) = 0.84; P = 0.0024), used as a measure of c
ytochrome P4501A2 (CYP1A2) activity. N1- and N7-demethylation indices
of caffeine also reflect CYP1A2 activity and were also correlated with
clozapine clearance (r(s) = 0.89 and 0.85; P = 0.0013 and 0.0023; res
pectively). No significant relationships with xanthine oxidase and N-a
cetyl transferase activity, also assessed by a caffeine test, were fou
nd. This study suggests that clozapine is metabolised by CYP1A2 to a m
ajor extent.